HK1054695A1 - Oral administration preparation improved in absorbability - Google Patents

Oral administration preparation improved in absorbability

Info

Publication number
HK1054695A1
HK1054695A1 HK03107057A HK03107057A HK1054695A1 HK 1054695 A1 HK1054695 A1 HK 1054695A1 HK 03107057 A HK03107057 A HK 03107057A HK 03107057 A HK03107057 A HK 03107057A HK 1054695 A1 HK1054695 A1 HK 1054695A1
Authority
HK
Hong Kong
Prior art keywords
absorbability
oral administration
administration preparation
preparation improved
improved
Prior art date
Application number
HK03107057A
Other languages
English (en)
Inventor
Minoru Okada
Haruo Sugata
Toshiaki Horie
Tetsuo Kaneko
Original Assignee
Ssp Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ssp Co Ltd filed Critical Ssp Co Ltd
Publication of HK1054695A1 publication Critical patent/HK1054695A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK03107057A 2001-10-11 2003-09-30 Oral administration preparation improved in absorbability HK1054695A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001313977A JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤

Publications (1)

Publication Number Publication Date
HK1054695A1 true HK1054695A1 (en) 2003-12-12

Family

ID=19132362

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03107057A HK1054695A1 (en) 2001-10-11 2003-09-30 Oral administration preparation improved in absorbability

Country Status (5)

Country Link
JP (1) JP2003119141A (es)
KR (1) KR20030030882A (es)
CN (1) CN1219514C (es)
HK (1) HK1054695A1 (es)
TW (1) TWI244921B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4780907B2 (ja) * 2003-09-30 2011-09-28 小林製薬株式会社 催眠剤組成物
JP4721631B2 (ja) * 2003-09-30 2011-07-13 小林製薬株式会社 催眠剤組成物
JP5094899B2 (ja) * 2010-03-23 2012-12-12 小林製薬株式会社 催眠剤組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151132A (ja) * 1984-12-24 1986-07-09 Kanebo Ltd ビタミンｋ↓２経口剤の製造法
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPH10130171A (ja) * 1996-09-04 1998-05-19 Dot:Kk 経口投与用医薬組成物
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Also Published As

Publication number Publication date
TWI244921B (en) 2005-12-11
CN1219514C (zh) 2005-09-21
CN1411812A (zh) 2003-04-23
KR20030030882A (ko) 2003-04-18
JP2003119141A (ja) 2003-04-23

Similar Documents

Publication Publication Date Title
EG23943A (en) Flash-melt oral dosage formulation
EP1372392A4 (en) ORAL DOSAGE FORM CONTAINING NICOTINE
AU2256702A (en) Composition improved in solubility or oral absorbability
AU2002222567A1 (en) Composition improved in solubility or oral absorbability
DZ3313A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
HUP0401461A3 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HUP0203204A3 (en) Oral dosage forms
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
PL362172A1 (en) Medicinal compositions having improved absorbability
HUP0500638A3 (en) Flashmelt oral dosage formulation
AU2002251448A1 (en) Oral absorbed drugs
EP1447084A4 (en) LYOPHILIZED PHARMACEUTICAL PREPARATION
HK1054695A1 (en) Oral administration preparation improved in absorbability
PL365342A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
HK1065792A1 (en) 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
EP1188440A4 (en) MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION
IL142353A0 (en) Oral absorbed drugs
IL146383A0 (en) Oral absorbed drugs
GB0015361D0 (en) Improvements in pharmaceutical compositions
HK1047232A1 (zh) 口服劑型
GB0014497D0 (en) Oral dosage form
GB9925069D0 (en) Oral dosage form
GB0129980D0 (en) Improvements in pharmaceutical compositions
GB0129979D0 (en) Improvements in pharmaceutical compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100929